Human medicines European public assessment report (EPAR): Betmiga, mirabegron, Date of authorisation: 20/12/2012, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Accord, pregabalin, Date of authorisation: 28/08/2015, Revision: 19, Status: Authorised

14th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 3 July 2025, 12:30 (CEST) to 3 July 2025, 17:30 (CEST)

Highlight report from the 14th Industry stakeholder platform on research and development support

Minutes - PDCO minutes of the 17-20 June 2025 meeting

Veterinary medicines European public assessment report (EPAR): Felisecto Plus, selamectin,sarolaner, Date of authorisation: 26/04/2019, Revision: 2, Status: Withdrawn

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Iscover, clopidogrel, Date of authorisation: 14/07/1998, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 24, Status: Authorised